3804-250a
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00762476)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3804-250a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00993759 | Phase 2 | Aug 1, 2009 | Hill Top Research, The Dial Corporation, University of Virginia |
| NCT00762476 | Phase 2 | Aug 1, 2008 | Hill Top Research, The Dial Corporation, TKL Research, University of Virginia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hill Top Research | For profit | 2 | 0 | 1 | 2008 |
| The Dial Corporation | For profit | 2 | 2 | 1 | 2008 |
| University of Virginia | Academic/Hospital | 2 | 0 | 1 | 2008 |
| TKL Research | For profit | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1